Several immunofluorescence product schemes designed in recent years have landed and have patent protection.
Due to the small size of the market, medical device products generally prefer to implement landing solutions with the least number of parts, and mold opening costs become the largest cost prepayment.
Immunofluorescence detection is one of the main low-cost quantitative detection methods, which can better assess the health status of a certain indicator.
May the health management cause benefit millions of households as soon as possible, no longer bear the risk of health accidents, continue to work hard.